Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- NXTD +16.4%, AHGP +14.1%, SSW +9.1%, SOHU +8.7%, DO +7.5%, PDS+5%, NRZ +5%, ANFI +4.1%, DAN +3.3%, OIS +2.1%, HSBC +1.8%, SF+1.3%, SNY +1.3%, BTG +1.1%, DISCA +1.1%, ARLP +1%
M&A news:
- CHTR +6.7% (spokesperson says company is not interested in Sprint (S), but Softbank (SFTBY) might still be interested in CHTR acquisition, according to Reuters)
Other news:
- ETRM +4.3% (received approval from the Ministry of Health, Social Services, and Equality to initiate a clinical trial for the Gastric Vest System in Spain; Enrollment is expected to begin by early 2018)
- CLF +3.5% (commences $575 mln tack-on offering of its 5.75 percent senior guaranteed notes due 2025)
- NADL +2.4% (amends the revolving credit facility provided by Seadrill (SDRL))
- AMD +1.4% (unveiled new professional graphics cards)
- RIO +1.4% (Rio Tinto and Unifor union agree to 4 year agreement with 3% wage increase this year)
- JD +1.3% (in sympathy with BIDU upgrade)
- TMUS +1.2% (trading higher with CHTR and S)
- TSLA +1.1% (CEO Elon Musk confirms first Model 3 deliveries with 500K reservations in advance)
- WDC +0.9% (issues statement regarding the order of the Superior Court of California for the County of San Francisco)
- AZN +0.9% (receives Breakthrough Therapy Designation from FDA for Imfinzi)
Analyst comments:
- GPRO +3.1% (upgraded to Equal-Weight from Underweight at Morgan Stanley)
- AXGN +2.6% (initiated with a Outperform at Leerink Partners)
- BIDU +1.5% (upgraded to Buy from Neutral at Nomura)
- CRTO +1.4% (initiated with a Overweight at KeyBanc Capital Mkts)
- ICLR +1.3% (upgraded to Buy from Hold at SunTrust)
- CELG +0.7% (upgraded to Buy from Hold at Argus)